Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | MEDICARES | 1 | ₹16,576 |
| 2 | Schedule 2 | MEDICARES | 1 | ₹11,022 |
| 3 | Schedule 3 | LIFE LINE PHARMACY | 1 | ₹4,705 |
| 4 | Schedule 4 | MEDICARES | 1 | ₹221 |
| 5 | Schedule 5 | MEDICARES | 1 | ₹1,980 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
13 Jun 2023, 4:00 pmClosed
drugs and pharmaceutical product
4852005
GEM/2023/B/3525937
Two Packet Bid
Inj Darbepoetin 40mcg,Montelukast Levocetrizine Syp,Mometasone 100 metered Dosages 10 ml Nasal Spra
5 days
West Bengal; Darjeeling
Item wise evaluation
BOQ
8 documents required · 8 mandatory
3 yrs
₹31
80%
Exempted
13 Jun 2023
3 Jun 2023
13 Jun 2023
| Item No | Item Title | Description | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|---|
| 1 | Inj Darbepoetin 40mcg | Inj Darbepoetin 40mcg | 20 | PFS | DARJEELING | 5 |
| 2 | Montelukast Levocetrizine Syp | Montelukast & Levocetrizine Syp | 600 | Bott | DARJEELING | 5 |
| 3 | Mometasone 100 metered Dosages 10 ml Nasal Spray | Mometasone 100 metered Dosages 10 ml Nasal Spray | 50 | Bott | DARJEELING | 5 |
| 4 | Tab Clinidipine 10 mg | Tab Clinidipine 10 mg | 650 | No | DARJEELING | 5 |
| 5 | Tab L-Carnitine 500 mg | Tab L-Carnitine 500 mg | 600 | No | DARJEELING | 5 |
| 6 | Tab Apixaban 5mg | Tab Apixaban 5mg | 800 | No | DARJEELING | 5 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_4852005.pdf
GEM_BID
re-04_2023-06-03-15-03-22_0c3522b077baa715fb17b5d12821e23a.pdf
BOQ
boq_item_sample_file-2_2023-06-03-15-03-22_7f345e25a920584deff53672a3c9996f.csv
BOQ
1685785067.xlsx
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .